Hallucinations (Hallucination)
1410
relevant articles (77 outcomes,
72 trials/studies)
found for this Disease
Description:
Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
Also Known As:
Hallucination; Visual Hallucinations; Auditory Hallucinations; Hallucination, Visual; Somatic Hallucinations; Visual Hallucination; Hallucination of Body Sensation; Hallucinations, Auditory; Hallucinations, Dissociative; Hallucinations, Elementary; Hallucinations, Formed, of People; Hallucinations, Gustatory; Hallucinations, Hypnagogic; Hallucinations, Hypnapompic; Hallucinations, Internal Body Sensation; Hallucinations, Kinesthetic; Hallucinations, Mood Congruent; Hallucinations, Mood Incongruent; Hallucinations, Olfactory; Hallucinations, Organic; Hallucinations, Reflex; Hallucinations, Sensory; Hallucinations, Somatic; Hallucinations, Tactile; Hallucinations, Verbal Auditory; Hallucinations, Visual; Hallucinations, Visual, Formed; Hallucinations, Visual, Unformed; Auditory Hallucination; Auditory Hallucination, Verbal; Auditory Hallucinations, Verbal; Body Sensation Hallucination; Body Sensation Hallucinations; Dissociative Hallucination; Dissociative Hallucinations; Elementary Hallucination; Elementary Hallucinations; Gustatory Hallucination; Gustatory Hallucinations; Hallucination, Auditory; Hallucination, Dissociative; Hallucination, Elementary; Hallucination, Gustatory; Hallucination, Hypnagogic; Hallucination, Hypnapompic; Hallucination, Kinesthetic; Hallucination, Mood Congruent; Hallucination, Mood Incongruent; Hallucination, Olfactory; Hallucination, Organic; Hallucination, Reflex; Hallucination, Sensory; Hallucination, Somatic; Hallucination, Tactile; Hallucination, Verbal Auditory; Hypnagogic Hallucination; Hypnagogic Hallucinations; Hypnapompic Hallucination; Hypnapompic Hallucinations; Kinesthetic Hallucination; Kinesthetic Hallucinations; Mood Congruent Hallucination; Mood Congruent Hallucinations; Mood Incongruent Hallucination; Mood Incongruent Hallucinations; Olfactory Hallucination; Olfactory Hallucinations; Organic Hallucination; Organic Hallucinations; Reflex Hallucination; Reflex Hallucinations; Sensory Hallucination; Sensory Hallucinations; Somatic Hallucination; Tactile Hallucination; Tactile Hallucinations; Verbal Auditory Hallucination; Verbal Auditory Hallucinations
Relationship Network
Disease Context: Research Results
Related Diseases
Experts
| 1. | Masdrakis, Vasilios G:
2 articles
(04/2008 - 10/2007)
|
| 2. | Soldatos, Constantin R:
2 articles
(04/2008 - 10/2007)
|
| 3. | Alonso-Navarro, H:
2 articles
(05/2007 - 03/2006)
|
| 4. | Jiménez-Jiménez, F J:
2 articles
(05/2007 - 03/2006)
|
| 5. | Friess, E:
2 articles
(03/2007 - 10/2000)
|
| 6. | Ondo, William G:
2 articles
(08/2005 - 09/2002)
|
| 7. | Cohen, S Y:
2 articles
(08/2003 - 06/2000)
|
| 8. | Quentel, G:
2 articles
(08/2003 - 06/2000)
|
| 9. | Tadayoni, R:
2 articles
(08/2003 - 06/2000)
|
| 10. | Fernandez-Capitan, C:
1 article
(09/2008)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Hallucinations:
| 1. | Antipsychotic Agents (Antipsychotics)IBA
|
| 2. | Clozapine (Clozaril)FDA LinkGeneric
|
| 3. | salicylhydroxamic acid (SHAM)IBA
|
| 4. | olanzapine (Zyprexa)FDA Link
02/01/2008
- " An improved total Brief Psychiatric Rating Scale (BPRS) score was not correlated with the plasma olanzapine concentration, but individual BPRS scores related to improvement of suspiciousness, hallucinations, and blunted affect were significantly correlated with plasma olanzapine concentration" 01/01/2001
- " RESULTS: Of the patients without hallucinations or delusions at baseline (N = 75), the placebo-treated patients showed significantly greater development of these symptoms compared with olanzapine-treated patients overall (NPI/NH hallucinations + delusions mean change score, +2.73 vs. +0.27, p = .006)" 07/01/2005
- " Therapy with olanzapine (OLZ) 5 mg/day led to a progressive clearance of visual hallucinations in seven days and was gradually reduced and withdrawn" 09/01/2002
- " We conducted a double-blind, placebo-controlled, unforced titration, parallel design study (2:1 drug to placebo randomization ratio) using olanzapine (2.5-10 mg/day to effect) in 30 PD patients with drug-induced hallucinations" 07/01/2004
- " Hypnopompic hallucinations during olanzapine treatment."
Get all the results and reference details, order at left...
|
| 5. | quetiapine (Seroquel)FDA Link
12/01/2006
- " The results show that quetiapine is effective in reducing behavioral symptoms, deliria and hallucinations, aggressiveness, and sleep disturbances" 01/01/2004
- " CONCLUSIONS: Quetiapine was effective in the treatment of hallucinations and delusions in PD" 02/01/2000
- " Quetiapine was markedly effective in controlling visual hallucinations in six of these patients" 03/01/1999
- " Several large, placebo- and active-controlled, multicenter trials have shown quetiapine to be effective against both positive (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy) and to have benefits in reducing hostility, aggression and affective symptoms" 01/01/2004
- " We set out to demonstrate the short- and long-term efficacy of quetiapine, an antipsychotic drug, in controlling hallucinations and delusions in parkinsonian patients without worsening their motor function"
Get all the results and reference details, order at left...
|
| 6. | Cholinesterase Inhibitors (Anticholinesterases)IBA
|
| 7. | Clomipramine (Anafranil)FDA LinkGeneric
|
| 8. | LithiumIBA
|
| 9. | donepezil (Aricept)FDA Link
|
| 10. | Antidepressive Agents (Antidepressants)IBA
|
| 535 Drugs and Important Bio-Agents
and
1271
more articles analyzed in the Full Patient-Physician Summary Report, order at left...
|
Therapies and Procedures
| 1. | Aftercare (After-Treatment)
|
| 2. | Drug Therapy (Chemotherapy)
|
| 3. | Renal Dialysis (Hemodialysis)
|
| 4. | Institutionalization (Institutionalized Persons)
10/01/2005
- " Presence of hallucinations is also associated with institutionalization and mortality." 08/01/2004
- " RESULTS: In multivariate models, adjusted for demographic and social variables, four clinical features emerged as the predominant predictors of institutionalization: cognitive impairment level, physical aggression, hallucinations and depressive symptoms" 08/01/2000
- " CONCLUSIONS: Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor" 10/01/1995
- " Symptoms of this nature, which can include frightening hallucinations or anxiety of phobic proportions, are subjectively distressing and can lead both to unsafe or violent situations as well as to the preventable use of inappropriate medication, physical restraint, and frequently to institutionalization" 08/01/2000
- " This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease."
Get all the results and reference details, order at left...
|
| 5. | Hearing Aids (Hearing Aid)
|
| 70 Therapies and Procedures
and
182
more articles analyzed in the Full Patient-Physician Summary Report, order at left...
|